Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Priorix vs M-M-R II Immunogenicity and Safety Study
NCT02058563Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2014
- Primary completion
- May 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of measles, mumps and rubella vaccine (live) in measles, mumps, rubella, sponsored by GSK. Started Jul 2014; status: completed.
02
Drugs
measles, mumps and rubella vaccine (live)
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT02058563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058563.